missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Angiopoietin-like 4 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity
Marke: R&D Systems™ 4487-AN-050
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
The Recombinant Human Angiopoietin-like 4 Protein is derived from NS0. The Recombinant Human Angiopoietin-like 4 Protein has been validated for the following applications: Inhibition Activity.
Spezifikation
| Lyophilized from a 0.2μm filtered solution in MOPS, NaCl and CHAPS. | |
| 43.6 kDa (monomer) | |
| 50 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 51129 | |
| Angiopoietin-like Protein 4/ANGPTL4 | |
| Mouse myeloma cell line,NS0-derived human Angiopoietin-like Protein 4/ANGPTL4 protein Gly26-Ser406 (Lys163Ala & Arg164Ala),with a C-terminal 6-His tag | |
| Oligomer | |
| Recombinant |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur